Building on our initial look at the Commission’s TPD evaluation, the Tobacco Advertising Directive (TAD) is now being reframed to treat all nicotine products—traditional or novel—as part of a single regulatory category. The emphasis is shifting from differentiated risk communication to a comprehensive, product‑agnostic ban on advertising, promotion, and sponsorship.
đź“‘ Key Shifts in Policy Thinking
• Expansion of scope:
TAPS rules proposed to cover existing and new tobacco and nicotine products, devices, accessories, and even “imitations.”
• Risk equivalence assumption:
Visibility of pouches or nicotine‑only devices treated as equivalent to cigarette advertising.
• Closing loopholes:
Innovation framed as “exploiting legal uncertainty,” driving calls for broad, future‑proof definitions across all media—including digital.
• Alignment with TPD:
E‑cigs already brought under TAD‑style bans; stakeholders now press for a consolidated directive.
• Comprehensive ban model:
Public‑health groups advocate harmonised EU‑wide prohibitions, leaving no differentiated space for reduced‑risk products.
⚖️ Implications
EU institutions and many health NGOs increasingly frame new nicotine products as public‑health threats to be controlled, not tools to help smokers move away from combustion. This narrative sidelines harm‑reduction potential and reinforces a one‑size‑fits‑all prohibitionist model.
đź’ˇ Key Takeaways for Industry
• The debate is no longer how new nicotine products should be advertised—it’s whether they should be advertised at all.
• Expect innovation to be regulated through horizontal bans and tax alignment, not risk‑proportionate frameworks.
• Strategic engagement will require highlighting the risks of conflating smoke‑free products with cigarettes, and the public‑health cost of ignoring relative risk.
